1-2 of 2
Jürgen Neesen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential Combination of Azacitidine and Lenalidomide Can Target the TP53 -Mutated Clone in Del(5q) Higher-Risk Myelodysplastic Syndromes

Uwe Platzbecker, MD, Friederike Braulke, Andrea Kuendgen, Katharina S. Götze, Gesine Bug, Katayoon Shirneshan, Christoph Röllig, Martin Bornhäuser, MD, Ralph Naumann, MD, Jürgen Neesen, Aristoteles Giagounidis, MD, Wolf-Karsten Hofmann, Gerhard Ehninger, Prof., Ulrich Germing, MD, Detlef Haase, Martin Wermke, MD
Journal: Blood
Blood (2012) 120 (21): 921.
https://doi.org/10.1182/blood.V120.21.921.921
Published: 2012
Journal Articles

Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities – Results of the “AZALE” Trial,

Uwe Platzbecker, MD, Christina Ganster, Jürgen Neesen, Andrea Kuendgen, MD, Katharina Götze, Gesine Bug, Katayoon Shirneshan, Friederike Braulke, Christoph Röllig, MD, Ralph Naumann, MD, Eckhard Büssemaker, Aristoteles Giagounidis, MD, Wolf-Karsten Hofmann, MD, Ulrich Germing, MD, Detlef Haase, Gerhard Ehninger, MD
Journal: Blood
Blood (2011) 118 (21): 3799.
https://doi.org/10.1182/blood.V118.21.3799.3799
Published: 2011